Search
for
Sort by
Research 601–630 of 1000+
- Biotransformation of Finasteride by Ocimum sanctum L., and tyrosinase inhibitory activity of transformed metabolites: Experimental and computational insights
- A validated RP-HPLC method to investigate finasteride in human skin after in vitro topically applying vesicular nanocarrier.
- Reversible Myopathy and Ophthalmoparesis After Low-Dose Finasteride Administration for Androgenic Alopecia
- Optimization of Finasteride Nano-Emulsion Preparation Using Chemometric Approach
- A retrospective study of clinical outcomes of α-blocker or finasteride monotherapy followed by combination therapy: determination of the period of combination therapy of α-blocker and finasteride
- Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?
- Hairless or fertile? Finasteride leads to epididymal changes and infertility in rats
- A Stability Indicating UPLC Method for Finasteride and Its Related Impurities
- Simultaneous Estimation of Finasteride and Tamsulosin Hydrochloride in Combined Dosage Forms by RP-HPLC-PDA Method
- UV SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF FINASTERIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM
- 5α-Reductase Inhibitors – The Finasteride Story
- Sensitive bromatometric assay methods for finasteride in pharmaceuticals
- Topical Finasteride in Hirsutism: A Double Blind Randomized Clinical Trial on Adult Women
- Influence of Liposomes and Niosomes on the In Vitro Permeation and Skin Retention of Finasteride
- Effects of finasteride on the morphology of polycystic ovaries
- Gynécomastie et finastéride (Propecia®) : 4 nouveaux cas
- Study on transdermal permeation and skin accumulation of finasteride ethosomes
- Doxazosin and finasteride alone or in combination: the PREDICT study
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Evaluation of men on finasteride.
- [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
- GYNECOMASTIA AFTER FINASTERIDE THERAPY
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Finasteride-Associated Central Serious Chorioretinopathy
- Finasteride blocks progesterone synthesis in MA-10 Leydig tumor cells
- “Comparison of QR 678 ® & QR678 ® Neo as monotherapy and as combination therapy with 5% Minoxidil solution and oral Finasteride in the treatment of male androgenetic alopecia—Which is better?”
- Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Synthesis and Evaluation of Finasteride-Loaded HPMC-Based Nanogels for Transdermal Delivery: A Versatile Nanoscopic Platform